| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d014aeb4e5b4a9f9b707cc445d036ea |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-16 |
| filingDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2470c24ad848d666fd0b1a375c3e683e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0868e90f55394dad0617812952ed1e9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0414767eca0217a559780110dbd3f90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fed966ba9f7eff617df25125ed8b765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5593bdd8c0de3a6b2be4c274c69736b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7646340009c0c72e14380ac1c32915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae33209cae2cc355519792775b3cb53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90700c29898bf0c53c98544dd5855bb0 |
| publicationDate |
2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2917183-A1 |
| titleOfInvention |
Bendamustine derivatives and methods of using same |
| abstract |
The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer: (I) wherein R1 is C6-C24alkyl or polyethylene glycol; and (II) wherein R2 is C1-C24alkylene; and R3 is-COOC1-3alkyl; or R2-R3 is C1-C24alkyl; or a pharmaceutically acceptable salt form thereof. |
| priorityDate |
2012-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |